Pinnetti, Carmela
 Distribuzione geografica
Continente #
NA - Nord America 697
EU - Europa 585
AS - Asia 227
AF - Africa 4
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.516
Nazione #
US - Stati Uniti d'America 693
DE - Germania 163
CN - Cina 120
SE - Svezia 107
UA - Ucraina 93
FR - Francia 88
SG - Singapore 49
IE - Irlanda 43
GB - Regno Unito 25
ID - Indonesia 22
FI - Finlandia 21
IT - Italia 16
RU - Federazione Russa 14
TR - Turchia 11
IN - India 9
JP - Giappone 5
BE - Belgio 3
ES - Italia 3
MX - Messico 3
NL - Olanda 3
TN - Tunisia 3
BG - Bulgaria 2
BR - Brasile 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
AF - Afghanistan, Repubblica islamica di 1
CA - Canada 1
DK - Danimarca 1
EU - Europa 1
HK - Hong Kong 1
KR - Corea 1
PL - Polonia 1
TJ - Tagikistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.516
Città #
Chandler 209
Jacksonville 47
San Mateo 42
Dublin 41
Singapore 36
Nanjing 35
Dearborn 30
Ashburn 29
Wilmington 24
Jakarta 22
New York 22
Lawrence 18
Ann Arbor 15
Nanchang 14
Woodbridge 14
Moscow 13
Izmir 11
Chicago 10
Houston 10
Lancaster 10
Redwood City 10
Munich 9
Jiaxing 8
Nürnberg 7
University Park 7
Kunming 6
Mountain View 6
Seattle 6
Boston 5
Hebei 5
Norwalk 5
Shanghai 5
Beijing 4
Boardman 4
Fremont 4
Guangzhou 4
Jinan 4
Princeton 4
Tianjin 4
Changchun 3
Changsha 3
Fairfield 3
Hangzhou 3
Helsinki 3
Marseille 3
Shenyang 3
Zhengzhou 3
Ames 2
Amsterdam 2
Bremen 2
Brussels 2
Buffalo 2
Cuauhtémoc 2
Hefei 2
Indiana 2
Milan 2
Philadelphia 2
Ponte Buggianese 2
Pune 2
Simi Valley 2
Sofia 2
São Lourenço 2
Tbilisi 2
Yellow Springs 2
Antwerpen 1
Augusta 1
Costa Mesa 1
Denver 1
Dushanbe 1
Edinburgh 1
Guiyang 1
Hanoi 1
Henderson 1
Jerusalem 1
Kabul 1
Kish 1
Kraków 1
Lanzhou 1
Las Vegas 1
Latina 1
Madrid 1
Mexico City 1
Naaldwijk 1
Newark 1
Novara 1
Nuremberg 1
Phoenix 1
Phoenixville 1
Quattro Castella 1
Rome 1
Sacramento 1
Seoul 1
Southend 1
Toronto 1
Wuhan 1
Totale 848
Nome #
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 122
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 120
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 109
Rubella susceptibility profile in pregnant women with HIV 95
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 85
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 79
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients 72
Rubella susceptibility profile in pregnant women with HIV 70
Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors 69
Glucose plasma levels and pregnancy outcomes in women with HIV 69
Pregnancy outcomes in women with advanced HIV infection in Italy 65
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens 63
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 63
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001-2011 61
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine 59
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 54
Glucose plasma levels and pregnancy outcomes in women with HIV 52
Pregnancy outcomes in women with advanced HIV infection in Italy 49
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 48
Immune characterization of the HBHA-specific response in mycobacterium tuberculosis-infected patients with or without HIV infection 45
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1 41
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: Data from the ICONA foundation study group, years 1997-2013 35
Totale 1.525
Categoria #
all - tutte 6.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 0 0 35 16 5 7 12 15 20
2020/2021171 2 21 3 21 24 10 19 3 27 11 27 3
2021/2022177 35 24 4 9 6 6 4 32 9 5 17 26
2022/2023437 49 68 38 81 39 52 8 28 54 2 10 8
2023/2024155 12 63 1 8 2 27 3 0 1 4 15 19
2024/202573 6 6 27 2 31 1 0 0 0 0 0 0
Totale 1.525